Skip to content

LivaNova LIVN Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Haemonetics logo
HaemoneticsHAE
Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR
ResMed logo
ResMedRMD
Solventum logo
SolventumSOLV
ICU Medical logo
ICU MedicalICUI

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's common stock, shares, outstanding?
LivaNova (LIVN) reported common stock, shares, outstanding of $54.9M in Q1 2026.
How has LivaNova's common stock, shares, outstanding changed year-over-year?
LivaNova's common stock, shares, outstanding increased by 0.7% year-over-year, from $54.52M to $54.9M.
What is the long-term trend for LivaNova's common stock, shares, outstanding?
Over 5 years (2020 to 2025), LivaNova's common stock, shares, outstanding has grown at a 2.4% compound annual growth rate (CAGR), from $48.66M to $54.65M.